<DOC>
	<DOC>NCT00977886</DOC>
	<brief_summary>The purpose of this trial is to study the safety and tolerability of repeated oral doses of ELB353, to evaluate the plasma levels of ELB353 and to study their effect on substances mediating inflammation.</brief_summary>
	<brief_title>Safety and Pharmacokinetics of ELB353 in Healthy Men</brief_title>
	<detailed_description />
	<criteria>Healthy Concomitant medication Concomitant disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>